GSK confirmed this morning that the disappointing readout from the DREAMM-3 trial of multiple myeloma therapy Blenrep reported earlier this month means that it will take the drug off the US market ...

Blenrep, which is predicted by analysts to produce revenues of around $1.5bn in 2026, is an antibody-drug conjugate that works by targeting B-cell maturation antigen (BCMA), a protein commonly ...

GSK sales hampered by slump in demand for key vaccine - The drugmaker said sales of Arexvy fell sharply in the third quarter, ...

We were particularly pleased to see the momentum now being established in our oncology business, and I'm delighted that we filed Blenrep in Europe, Japan, and the U.S. in the quarter. We also ...

A new mineral discovered recently in an abandoned gold mine in Hungary has been named kanatzidisite in honor of Greek scientist Mercouri Kanatzidis, an inorganic chemist at Northwestern University, ...

Q3 2024 Earnings Call Transcript October 30, 2024 GSK plc beats earnings expectations. Reported EPS is $1.29, expectations were $1.23. Operator: Hello, everyone. Welcome to today’s call and webcast.

Upon a potential return to the White House, Donald Trump has outlined a series of immediate actions for his first day and second term. These include dismissing legal cases against him, enacting ...

Teva Pharmaceutical Industries Ltd. ADR-2.23% $19.91B ...

101 years ago today, one of the most famous dogs in the world, Hachikō the Akita, was born in Ōdate. He is beloved, revered, ...

Nov. 8, 2024 — Researchers today are releasing the flagship dataset from an ambitious study of biomarkers and environmental factors that might influence the development of type 2 diabetes ...